Here are five points:
1. The University of Louisville is a clinical site and the data management center for the Christopher and Dana Reeve Foundation’s North American Clinical Trials Network for the Treatment of Spinal Cord Injury.
2. The hospital is the area’s only Level I Trauma Center.
3. Maxwell Boakye, MD, will serve as the site’s principal investigator. He is spinal neurosurgery chief and clinical director of the Kentucky Spinal Cord Injury Center and a neurosurgical surgery associate professor.
4. InVivo Therapeutics now has 17 participating clinical sites.
5. The INSPIRE study tests the safety and neurological recovery of the Neuro-Spinal Scaffold. It is intended for patients with complete traumatic acute spinal cord injury.
“I can appreciate the enormous unmet medical need presented by spinal cord injury, from both my experience as a practicing neurosurgeon and as a pharmacoeconomics researcher,” said Dr. Boakye.
More articles on devices:
Amedica, Celling Biosciences partner for biologically-enhanced implants: 5 key notes
ConforMIS fully launches iTotal PS for total knee replacement: 5 key notes
Bioventus to introduce 3 new products at AAOS 2016: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
